Hyderabad, January 30, 2026: India’s radiology and diagnostic imaging ecosystem is entering a new phase of growth, driven by rising life expectancy, increasing health awareness, and the expanding reach of public healthcare initiatives such as Ayushman Bharat, which are fueling demand for timely, accurate, and accessible diagnostics across the country. As imaging volumes grow across preventive, acute, and chronic care, there is a parallel need for advanced, scalable technologies that can support high-quality diagnosis while strengthening healthcare delivery beyond metro cities. Responding to these evolving needs, FUJIFILM India, a leader in advanced diagnostic imaging solutions, today announced the launch of Four new diagnostic imaging and healthcare IT solutions at the Indian Radiological and Imaging Association (IRIA) 2026, underscoring its commitment to strengthening India’s diagnostic imaging ecosystem through advanced, clinically validated, and workflow-centric technologies that enable diagnostic confidence, operational efficiency, and broader access across diverse clinical environments.
At the center of the showcase is FCT iStream, Fujifilm’s latest CT scan system, built on a “Less is More” design philosophy. FCT iStream combines high-definition imaging, dose optimization, and AI-enabled workflow automation powered by the Synergy-Drive workflow suite and REiLI Medical AI technologies. The CT scanner automates key steps across the imaging process, from patient positioning & scan planning to image reconstruction & seamless integration with SYNAPSE 3D Workstation for advanced visualization, helping radiology departments to manage rising patient volumes with greater efficiency and consistency. Advanced reconstruction and Organ-based dose modulation technologies further enable high diagnostic confidence at significantly reduced radiation doses, supporting a wide range of clinical applications including oncology, cardiology, neurology, trauma, and preventive health screening.
Complementing its CT offerings, FUJIFILM India also highlighted its women’s health imaging portfolio, led by advanced full-field digital mammography systems, including AMULET SOPHINITY and AI Designed with a strong focus on patient comfort and diagnostic precision, these mammography machines support early breast cancer detection through high-resolution imaging, AI-assisted positioning, tomosynthesis, and contrast-enhanced mammography capabilities. Together, they reinforce FUJIFILM India’s continued emphasis on preventive healthcare and improved screening outcomes, particularly in women’s health.
The portfolio further includes digital radiography (X-ray) systems, such as the FDR Smart X Essential series, engineered for reliability, flexibility, and efficient workflows in high-throughput clinical environments. Designed for deployment across tertiary hospitals, diagnostic centres, and space-constrained facilities, these X-ray systems combine consistent image quality with space-efficient configurations and streamlined operations, supporting broader access to essential radiography services across urban and non-metro settings. Option of inbuilt AI interface also available.
Underpinning the imaging portfolio is Fujifilm’s healthcare IT ecosystem, including enterprise imaging and data management platforms such as HCIT Fenix, along with advanced visualization solutions that enable seamless image access, interoperability, and clinical collaboration. By integrating imaging systems with intelligent software platforms, FUJIFILM India aims to support end-to-end diagnostic workflows while enabling faster clinical decision-making and optimized clinical operations. Developed under FUJIFILM India’s Make in India initiative, FENIX brings together PACS, RIS, Mobility, and smart workflow tools on a unified, scalable platform designed to meet the evolving needs of radiology practices across India. Built with a strong focus on performance, interoperability, and ease of use, FENIX supports faster diagnosis, seamless integration with existing systems, and flexible deployment across hospitals, diagnostic centres, and teleradiology networks. This launch reinforces FUJIFILM India’s long-term commitment to locally developed innovation that empowers radiologists, improves clinical efficiency, and enhances patient care.
Commenting on the showcase at IRIA 2026, Mr. Nobuo Matsunobe, General Manager, Modality Systems Division, Medical Systems Business, FUJIFILM Corporation, said, “Fujifilm’s healthcare innovation is driven by a deep focus on image quality, dose optimization, and workflow automation across modalities. The solutions showcased at IRIA 2026, from FCT iStream and AMULET SOPHINITY to FDR Smart X Essential, ARIETTA 750 DeepInsight, and our healthcare IT platforms, reflect our approach of combining AI-enabled technologies with clinician-centric design to address rising imaging volumes, optimize operational efficiency, and enhance diagnostic confidence. These technologies are designed to perform consistently across diverse clinical environments while meeting global standards of quality and reliability.”
Adding to this, Mr. Koji Wada, Managing Director, FUJIFILM India, said, “India’s diagnostic imaging needs are evolving rapidly, with increasing demand for accuracy, speed, and access across care settings. Our presence at IRIA 2026 reflects our group purpose of ‘Giving our world more smiles’ by supporting India’s healthcare providers with a comprehensive portfolio of advanced yet practical imaging and healthcare IT solutions. We are focused on strengthening diagnostic infrastructure by remaining committed to bringing our diverse ideas and unique capabilities together to change the world.”
With its expanded presence at IRIA 2026, FUJIFILM India further strengthens its position as a trusted healthcare technology partner, offering an integrated diagnostic imaging portfolio spanning CT, mammography, digital radiography, ultrasound, and healthcare IT. The company continues to focus on AI-enabled imaging, workflow automation, preventive healthcare, and clinician education, working closely with healthcare institutions to enable timely diagnosis, improve patient outcomes, and support India’s evolving healthcare priorities.
